Watchlist Price Alert

Xeris Biopharma Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

4.36

-0.06 (-1.36%)

At close: Jun 13, 2025, 3:59 PM

4.33

-0.69%

After-hours: Jun 13, 2025, 07:30 PM EDT

Xeris Biopharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	203.07M	163.91M	110.25M	49.59M	49.59M	20.16M	2.46M	1.56M	1.07M
Cost of Revenue	36.83M	28.64M	22.63M	13.32M	13.32M	9.33M	42K	4K	8K
Gross Profit	166.24M	135.27M	87.61M	36.27M	36.27M	10.83M	2.42M	1.55M	1.07M
Operating Income	-33.65M	-44.01M	-81.94M	-115.16M	-115.16M	-83.55M	-59.34M	-26.63M	-13.23M
Interest Income	5.32M	4.75M	2.58M	313K	313K	2.96M	1.61M	124K	5K
Pretax Income	-57.1M	-63.5M	-96.08M	-122.72M	-122.72M	-91.25M	-60.08M	-26.55M	-13.21M
Net Income	-54.84M	-62.26M	-94.66M	-122.72M	-122.72M	-91.14M	-60.08M	-26.55M	-13.21M
Selling & General & Admin	163.48M	146.09M	137.75M	125.72M	125.72M	73.73M	21.11M	8.02M	4.06M
Research & Development	25.56M	22.34M	20.97M	25.16M	25.16M	20.92M	40.65M	20.17M	10.24M
Other Expenses	10.84M	10.84M	10.84M	550K	550K	-280K	n/a	-1K	-5K
Operating Expenses	199.88M	179.28M	169.55M	151.43M	151.43M	94.37M	61.77M	28.18M	14.3M
Interest Expense	33.17M	26.61M	14.1M	7.18M	7.18M	10.66M	2.54M	2K	2K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	236.72M	207.92M	192.19M	164.75M	164.75M	103.7M	61.81M	28.18M	14.31M
Income Tax Expense	-2.27M	-1.25M	-1.42M	n/a	-110K	-110K	1.81M	1K	-3K
Shares Outstanding (Basic)	146.77M	137.67M	135.63M	79.03M	42.64M	26.11M	12.05M	2.03M	1.84M
Shares Outstanding (Diluted)	146.77M	137.67M	135.63M	79.03M	42.64M	26.11M	12.05M	2.03M	1.84M
EPS (Basic)	-0.37	-0.45	-0.7	-1.55	-2.88	-3.49	-4.99	-13.09	-7.17
EPS (Diluted)	-0.37	-0.45	-0.7	-1.55	-2.88	-3.49	-4.99	-13.09	-7.17
EBITDA	-11.3M	-23.73M	-69.31M	-113.67M	-80.08M	-117.8M	-57.22M	-26.38M	-13.09M
EBIT	-26.62M	-36.9M	-81.98M	-115.55M	-80.59M	-118.88M	-57.53M	-26.55M	-13.21M
Depreciation & Amortization	12.63M	13.16M	12.67M	1.88M	1.47M	1.08M	320K	177K	116K